Phase I/II adaptive dose-finding design for combination
studies. Several methods are proposed depending on the type of
combinations: (1) the combination of two cytotoxic agents, and (2)
combination of a molecularly targeted agent with a cytotoxic agent.
| Version: |
2.1-5 |
| Depends: |
R (≥ 3.1.3) |
| LinkingTo: |
RcppArmadillo (≥ 0.4.650), BH (≥ 1.55), RcppProgress (≥
0.2.1), Rcpp |
| Published: |
2015-10-05 |
| Author: |
Marie-Karelle Riviere and Jacques-Henri Jourdan |
| Maintainer: |
Marie-Karelle Riviere <eldamjh at gmail.com> |
| License: |
GPL-3 |
| Copyright: |
src/arms.c and src/arms.h are copyright Wally Gilks. All
other files are copyright Institut de Recherches
Internationales Servier and Institut national de la sante et de
la recherche medicale. |
| NeedsCompilation: |
yes |
| CRAN checks: |
dfcomb results |